From genes to pain:: Nav1.7 and human pain disorders

被引:204
|
作者
Dib-Hajj, Sulayman D.
Cummins, Theodore R.
Black, Joel A.
Waxman, Stephen G.
机构
[1] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA
[2] Yale Univ, Sch Med, Ctr Neurosci & Regenerat Res, New Haven, CT 06510 USA
[3] VA Connecticut Healthcare Syst, Rehabil Res Ctr, West Haven, CT 06516 USA
[4] Indiana Univ, Sch Med, Stark Neurosci Inst, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA
关键词
D O I
10.1016/j.tins.2007.08.004
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Gain-of-function mutations or dysregulated expression of voltage-gated sodium channels can produce neuronal hyperexcitability, leading to acute or chronic pain. The sodium channel Na(v)1.7 is expressed preferentially in most slowly conducting nociceptive neurons and in sympathetic neurons. Gain-of-function mutations in the Na(v)1.7 channel lead to DRG neuron hyperexcitability associated with severe pain, whereas loss of the Na(v)1.7 channel in patients leads to indifference to pain. The contribution of Na(v)1.7 to acquired and inherited pain states and the absence of motor, cognitive and cardiac deficits in patients lacking this channel make it an attractive target for the treatment of neuropathic pain.
引用
收藏
页码:555 / 563
页数:9
相关论文
共 50 条
  • [31] Development of an equipotent NaV1.1 and NaV1.7 inhibitor for the treatment of chronic visceral pain
    Eagles, David
    King, Glenn
    Cardoso, Fernanda
    Muttenthaler, Markus
    Brierley, Stuart
    JOURNAL OF PEPTIDE SCIENCE, 2024, 30
  • [32] Neuropathic pain develops normally in mice lacking both Nav1.7 and Nav1.8
    Nassar, Mohammed A.
    Levato, Alessandra
    Stirling, L. Caroline
    Wood, John N.
    MOLECULAR PAIN, 2005, 1
  • [33] Discovery of XEN907, a spirooxindole blocker of NaV1.7 for the treatment of pain
    Chowdhury, Sultan
    Chafeev, Mikhail Mikhail
    Liu, Shifeng
    Sun, Jianyu
    Raina, Vandna Vandna
    Chui, Ray
    Young, Wendy Wendy
    Fu, Jianmin Jianmin
    Cadieux, Jay A. Jay A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
  • [34] Infrequent NaV1.7 Mutation in Insensitivity to Pain, Erythromelalgia and Small Fiber Neuropathy
    Klein, Christopher J.
    Kilfoyle, Dean H.
    Wu, Yanhong
    Sandroni, Paola
    Low, Phillip A.
    Davis, Mark D.
    Dyck, Peter J.
    ANNALS OF NEUROLOGY, 2012, 72 : S23 - S23
  • [35] Hydropathicity-based prediction of pain-causing NaV1.7 variants
    Xenakis, Makros N.
    Kapetis, Dimos
    Yang, Yang
    Gerrits, Monique M.
    Heijman, Jordi
    Waxman, Stephen G.
    Lauria, Giuseppe
    Faber, Catharina G.
    Westra, Ronald L.
    Lindsey, Patrick J.
    Smeets, Hubert J.
    BMC BIOINFORMATICS, 2021, 22 (01)
  • [36] Inhibition of the Nav1.7 Channel in the Trigeminal Ganglion Relieves Pulpitis Inflammatory Pain
    Kwon, Minjee
    Jung, Il Young
    Cha, Myeounghoon
    Lee, Bae Hwan
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [37] Phytol from Faeces Bombycis alleviated migraine pain by inhibiting Nav1.7 sodium channels
    Song, Jianan
    Jiang, Mengyuan
    Jin, Yuchen
    Li, Hongrui
    Li, Yanhong
    Liu, Yumei
    Yu, Haibo
    Huang, Xiangzhong
    JOURNAL OF ETHNOPHARMACOLOGY, 2023, 306
  • [38] Upregulation of Nav1.7 by endogenous hydrogen sulfide contributes to maintenance of neuropathic pain
    Tian, Jun-Jie
    Tan, Chao-Yang
    Chen, Qin-Yi
    Zhou, Ying
    Qu, Zu-Wei
    Zhang, Meng
    Ma, Ke-Tao
    Shi, Wen-Yan
    Li, Li
    Si, Jun-Qiang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2020, 46 (02) : 782 - 794
  • [39] Development of New Benzenesulfonamides As Potent and Selective Nav1.7 Inhibitors for the Treatment of Pain
    Wu, Yong-Jin
    Guernon, Jason
    Shi, Jianliang
    Ditta, Jonathan
    Robbins, Kevin J.
    Rajamani, Ramkumar
    Easton, Amy
    Newton, Amy
    Bourin, Clotilde
    Mosure, Kathleen
    Soars, Matthew G.
    Knox, Ronald J.
    Matchett, Michele
    Pieschl, Rick L.
    Post-Munson, Debra J.
    Wang, Shuya
    Herrington, James
    Graef, John
    Newberry, Kimberly
    Bristow, Linda J.
    Meanwell, Nicholas A.
    Olson, Richard
    Thompson, Lorin A.
    Dzierba, Carolyn
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (06) : 2513 - 2525
  • [40] Neuropathic pain associated with Nav1.7 mutations. Clinical picture and treatment
    Doppler, K.
    Sommer, C.
    NERVENARZT, 2013, 84 (12): : 1428 - +